Canbi  Pharma  Tech  Cyfyngedig
1792180-81-4 Ritlecitinib
1792180-81-4 Ritlecitinib

1792180-81-4 ritlecitinib

Cas: 1792180-81-4
MF: C15H19N5O
MW: 285.34
EINECS: 210-077-2
MDL Rhif:mfcd31697544

Anfon ymchwiliad
Disgrifiad

Eiddo

Ymddangosiad gwyn i bowdr llwydfelyn
Dwysedd 1.272 ± 0. 06 g/cm3
Temp Storio. temp ystafell
hydoddedd dmso: 1 0 0.0 (Max conc. mg/ml); 350.4 (Max conc. mm)
H2O: 5. 0 (Max conc. Mg/ml); 17.5 (Max conc. Mm)
PKA13. 0 3 ± 0.50
 

Cais:

Mae Ritlecitinib yn atalydd kinase sy'n addas ar gyfer trin areata alopecia difrifol mewn oedolion a'r glasoed 12 oed neu'n hŷn.

 

Cyfystyron:

1792180-81-4

Cynhyrchion

1- ((2s, 5r) -5- ((7h-pyrrolo [2, {3- d] pyrimidin -4- yl) amino) {{}} MethylpipiDin}}}}}}}

1- [(2s, 5r) {-2- methyl -5- (7h-pyrrolo [2, 3- d] pyrimidin -4- ylamino un}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

{2- prop prop {-1- un, 1- ((2s, 5r) -2- methyl -5- (7H-pyrrolo (2, {3- d) pyrimidin-pyrimidin}}}}}}}}}}}}}}}}}}}}}}

ritlecitinibum

Ritlecitinib (Ritlecitinib)

1- ((2s, 5r) {-2- methyl -5- ((7h-pyrrolo (2, {3- d) pyrimidin -4- yl) amino) piperidin}}}}}}}}

1- ((2s, 5r) {-2- methyl -5- (7h-pyrrolo (2, 3- d) pyrimidin -4- yLamino}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}}

C15H19N5O

Chebi: 229233

Ritlecitinib (pf -06651600)

Atalydd jak3 pf -06651600

1- (5- ((7h-pyrrolo (2, 3- d) pyrimidin {-4- yl) amino) -2- methylpiperidin {}}}} yl)

 

 

Tagiau poblogaidd: 1792180-81-4 ritlecitinib, China 1792180-81-4 gwneuthurwyr ritlecitinib, cyflenwyr

Inquiry
goTop

(0/10)

clearall